Litcius/Paper detail

Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis

Huzaifa Ahmad Cheema, Uzair Jafar, Asmaa Ahmed Elrashedy, Abia Shahid, Rehmat Ullah Awan, Muhammad Ehsan, Muhammad Ayyan, Syeda Sahra

2022Journal of Infection16 citationsDOIOpen Access PDF

Topics & Concepts

FluvoxamineMeta-analysisCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBetacoronavirusMEDLINEIntensive care medicineInternal medicineVirologyBiologyFluoxetineOutbreakReceptorInfectious disease (medical specialty)BiochemistryDiseaseSerotoninPharmacological Receptor Mechanisms and EffectsPhenothiazines and Benzothiazines Synthesis and ActivitiesCancer therapeutics and mechanisms
Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis | Litcius